Understand the source comparison
Peptide Clinics Washington Providers Services 2026: Type Comparison
| Provider Type | Regulatory Oversight | Prescription Required | Compound Source | Insurance Coverage | Cost Range (Monthly) | Professional Assessment ||—|—|—|—|—|—|| Telemedicine + FDA-Approved Peptides | Washington medical board + FDA drug approval | Yes. Li
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Provider Type | Regulatory Oversight | Prescription Required | Compound Source | Insurance Coverage | Cost Range (Monthly) | Professional Assessment ||—|—|—|—|—|—|| Telemedicine + FDA-Approved Peptides | Washington medical board + FDA drug approval | Yes. Licensed prescriber evaluation | Retail or mail-order pharmacy (FDA-approved drugs) | Partial coverage for diabetes indication; inconsistent for obesity | $900–$1,400 | Highest regulatory assurance and clinical validation. Limited to narrow range of approved peptide drugs (GLP-1s primarily). Best option for patients prioritising insurance reimbursement and full FDA oversight. || Hybrid Clinic + 503B Compounded Peptides | Washington medical board + FDA 503B facility registration | Yes. Licensed prescriber evaluation | Registered 503B outsourcing facility | No insurance coverage; out-of-pocket only | $250–$450 | Moderate regulatory oversight with broader compound access. Requires verifiable 503B sourcing and batch documentation. Best